views
Decks have become the modern currency of credibility. Consultants trade them. Bankers weaponise them. Operators tolerate them. Somewhere between analysis and action, we decided that design equals depth. That if it's animated, it must be insightful. The medium became the message......and the message got lost. In consulting,
views
Somewhere along the way, we made “busy” a personality trait. Ask anyone how they’ve been and the default answer is the same: “Busy.” Like it’s proof of relevance. A humblebrag wrapped in exhaustion. People wear their overcommitment like armour. Too busy to think. Too busy to prioritise. Too
views
Hard decisions don’t get easier with time. They get heavier. Every leader knows the moment a difficult call presents itself. A hire who isn’t landing. A vendor who keeps missing. A product that isn’t resonating. A structure that clearly isn’t working. And yet the instinct is
deals
Heightened State Oversight Signals Investors to Refresh Health-Care Investment Playbooks Starting January 1, 2026, California is rolling out new laws (AB 1415 and SB 351) that significantly tighten regulation of private-equity and hedge-fund involvement in health-care transactions. The rules restrict non-clinical entities from influencing medical decision-making, expand oversight of Management
deals
Blackstone Takes Alexander & Baldwin Private in $2.3 Billion Deal Blackstone is taking Alexander & Baldwin private for $2.3 billion, giving public shareholders a fat premium and relieving a small-cap Hawaiian REIT from the existential boredom of quarterly reporting. A&B owns grocery-anchored retail and industrial boxes
theses
Every healthcare investor knows the story: the clinic looks profitable on paper, but when you lift the hood, there’s 10–15% of revenue sitting in limbo...unpaid claims, coding errors, rejected reimbursements. It’s not a demand problem. It’s a billing problem. The U.S. healthcare system processes
views
It’s theirs. You’re just renting demand at a premium. Aggregators and PPL platforms exist for one reason, to own customer intent. They dominate search, intercept leads at the point of need, and sell that intent back to you. You’re buying access to your own market. It’s
views
The “Value Creation Plan” (VCP) has become a kind of corporate theatre.....a glossy internal pitch deck designed to impress LPs, not to actually change how portfolio companies run. It’s full of big promises: digital transformation, pricing excellence, sales enablement. Then it disappears into the ether the moment the
news
U.S. PE Exits Finally Show Real Momentum Again PitchBook data shows U.S. private equity exits are on track for a second straight year of recovery, with ~1,300 exits through October generating $621.7B. After two years of gridlock, this is the first real sign that LP liquidity
deals
Shore Capital Merges Reliant Healthcare & Care Fusion Rx to Launch a National Infusion-Therapy Platform Shore Capital has merged Reliant Healthcare, a home-infusion and ambulatory-infusion-center provider operating 14 centers (in Louisiana, Texas, and Oklahoma) plus specialty pharmacies, with Care Fusion Rx, a West-Coast specialty infusion pharmacy focused on complex biologics
life
A new rundown of high-end tech accessories highlights what’s replacing traditional “status buys”: premium headphones, elevated everyday carry, and wearables designed to integrate into work and travel, not shout for attention. Luxury is shifting from logo-centric to performance-centric. Link
views
The old model of fundraising was built on mystique. You built a brand, hired a placement agent, assembled a glossy deck full of logos, exits, and hockey-stick IRRs, and flew around the world collecting commitments based on trust or legacy. LPs weren’t really buying performance. They were buying reputation.